Showing posts with label Top-Line Results from Phase 2b/3 Clinical Trial of Emixustat. Show all posts
Showing posts with label Top-Line Results from Phase 2b/3 Clinical Trial of Emixustat. Show all posts
Friday, March 10, 2017

Acucela Announces Top-Line Results from Phase 2b/3 Clinical Trial of Emixustat

›
Acucela Inc.  a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow t...